- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01667835
South Asian Women & Yoga Education Study (SAWYES)
16 de noviembre de 2012 actualizado por: Dr. Amandah Hoogbruin, Kwantlen Polytechnic University
Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study
The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease.
Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques.
The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
Descripción general del estudio
Estado
Desconocido
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Anticipado)
50
Fase
- Fase 1
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
British Columbia
-
Surrey, British Columbia, Canadá, V3T 0G9
- Reclutamiento
- The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic
-
Contacto:
- Amandah L Hoogbruin, PhD
- Número de teléfono: 604 599 3144
- Correo electrónico: amandah.hoogbruin@kwantlen.ca
-
Contacto:
- Raymond Dong, FRCP(c)
- Número de teléfono: 604 686 6372
- Correo electrónico: raydongheart@gmail.com
-
Surrey, British Columbia, Canadá, V3W 2M8
- Aún no reclutando
- Kwantlen Polytechnic University
-
Contacto:
- Amandah L Hoogbruin, PhD
- Número de teléfono: 604 599 3144
- Correo electrónico: amandah.hoogbruin@kwantlen.ca
-
Contacto:
- Raymond Dong, FRCPC
- Número de teléfono: 604 838 8418
- Correo electrónico: raydongcardio@gmail.com
-
Investigador principal:
- Amandah L Hoogbruin, PhD
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
40 años a 65 años (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Femenino
Descripción
Inclusion Criteria:
- 40- 65 years old
- Postmenopausal (amenorrhea for ≥ 12 months)
- Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension
- Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)
- Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere
- Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.
Exclusion Criteria:
- Have had a period within the last year
- Are not between the ages of 40 and 65
- Have experience with yoga within the last 12 months
- Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)
- Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke
- Have a severe infectious or other medical illness right now such as pneumonia
- Use medications to lower blood sugar levels
- Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program
- Regularly use an assistive device (e.g., cane, walker) to walk
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control
|
|
|
Experimental: Intervención de yoga
|
12 week 90 minute hatha yoga session offered three (3x) per week.
Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques.
The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in blood pressure
Periodo de tiempo: baseline, at end of study (12 wks), & 3 months post-study
|
blood pressure is measured as a specific physiologic index of cardiovascular risk.
|
baseline, at end of study (12 wks), & 3 months post-study
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in subjective well-being
Periodo de tiempo: baseline, at end of study (12 wks), & 3 months post-study
|
The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
|
baseline, at end of study (12 wks), & 3 months post-study
|
|
Change in perceived physical well-being
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in insulin sensitivity
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in inflammation
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum total cholesterol
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Serum total cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum high-density lipoprotein (HDL) cholesterol
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum low-density lipoprotein (LDL) cholesterol
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum triglycerides
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Serum triglycerides will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in waist circumference.
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change waist-hip ratio
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in body mass index (BMI)
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in resting heart rate
Periodo de tiempo: baseline, end of study (12 wks) & 3 months post-study
|
Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in heart rate
Periodo de tiempo: baseline, at end of study (12 wks), & 3 months post-study
|
Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
|
baseline, at end of study (12 wks), & 3 months post-study
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Amandah L Hoogbruin, PhD, Kwantlen Polytechnic University
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de noviembre de 2012
Finalización primaria (Anticipado)
1 de diciembre de 2014
Finalización del estudio (Anticipado)
1 de agosto de 2015
Fechas de registro del estudio
Enviado por primera vez
17 de junio de 2012
Primero enviado que cumplió con los criterios de control de calidad
14 de agosto de 2012
Publicado por primera vez (Estimar)
17 de agosto de 2012
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
19 de noviembre de 2012
Última actualización enviada que cumplió con los criterios de control de calidad
16 de noviembre de 2012
Última verificación
1 de noviembre de 2012
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- KK11-04
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .